LYB001 explained

Type:vaccine
Target:SARS-CoV-2
Vaccine Type:vlp
Routes Of Administration:Intramuscular

LYB001 is a COVID-19 vaccine candidate developed by Yantai Patronus Biotech Co., Ltd.

It was found to be safe and well tolerated.[1]

Notes and References

  1. Tang R, Zeng Y, Zhou Y, Liang Q, Kang W, Yang Z, Zheng X, Zang X, Pan H, Jin J, Zhu F . Safety and immunogenicity of the SARS-CoV-2 LYB001 RBD-based VLP vaccine (CHO cell) phase 1 in Chinese adults: a randomized, double-blind, positive-parallel-controlled study . Expert Review of Vaccines . 23 . 1 . 498–509 . 2 May 2024 . 38695310 . 10.1080/14760584.2024.2337051 . free .

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "LYB001".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2025, A B Cryer, All Rights Reserved. Cookie policy.